Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Fumarate and Efavirenz, lamivudine, and tenofovir

• Generic Name: cobicistat / darunavir / emtricitabine / tenofovir alafenamide
• Dosage Forms: n.a.
• Other Brand Names: Symtuza

Darunavir, cobicistat, emtricitabine, and tenofovir alafenamide fumarate is a four-drug combination of darunavir (DRV), an HIV-1 protease inhibitor, cobicistat (COBI), a CYP3A inhibitor, and emtricitabine (FTC) and tenofovir alafenamide (TAF), both HIV-1 NRTIs, and is indicated as a complete regimen for the treatment of HIV-1 infection in adults who have no prior antiretroviral treatment history or who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen for at least 6 months and have no known substitutions associated with resistance to darunavir or tenofovir.

• Generic Name: efavirenz / lamivudine / tenofovir
• Dosage Forms: n.a.
• Other Brand Names: Symfi, Symfi Lo

Efavirenz, lamivudine, and tenofovir is a combination antiviral medicine that is used to treat human immunodeficiency virus (HIV). HIV is the virus that can cause acquired immunodeficiency syndrome (AIDS). efavirenz, lamivudine, and tenofovir is not a cure for HIV or AIDS.

Symfi is for use in adults and children who weigh at least 88 pounds (40 kilograms).

Symfi Lo is for use in adults and children who weigh at least 77 pounds (35 kilograms).

Efavirenz, lamivudine, and tenofovir may also be used for purposes not listed in this medication guide.